A Study of the Safety and Tolerance of CAN04 and Pembrolizumab in Combination With and Without Carboplatin and Pemetrexed in Subjects With Solid Tumors

Clinical trial NCT04452214 · COMPLETED

Trial details

NCT number: NCT04452214
Sponsor: Cantargia AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Urothelial Carcinoma Malignant Melanoma Head and Neck Squamous Cell Carcinoma

Start date: 2020-09-24
Primary completion: 2023-06-28
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.